Moderna COVID-19 vaccine doubles level of antibodies versus Pfizer shot: study
Moderna’s COVID-19 vaccine more than doubled the level of antibodies compared to the Pfizer vaccine, according to a study of healthcare workers in Belgium, researchers found.